Rune Labs

Rune Labs

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $25.6M

Overview

Rune Labs is a private, San Francisco-based digital health company founded in 2018, operating at the intersection of neuroscience, AI, and data analytics. Its core offering is the StrivePD ecosystem, an FDA-cleared platform that uses the Apple Watch to collect Parkinson's symptom data, enabling personalized patient care and providing real-world datasets for clinical research. The company generates revenue by offering its StriveStudy platform and data services to life sciences companies for clinical trials, real-world evidence, and commercial support, while also serving clinicians and patients directly. Rune Labs has established key partnerships with healthcare providers like Kaiser Permanente and biotech firms like BlueRock Therapeutics.

Parkinson's DiseaseMultiple SclerosisObsessive-Compulsive DisorderEssential Tremor

Technology Platform

Cloud-based software and data analytics platform for precision neurology. Integrates multi-modal data from wearables (FDA-cleared Apple Watch integration), patient apps, EMR, and neuromodulation devices. Enables remote patient monitoring, personalized care dashboards for clinicians, and GCP-compliant clinical trial support including digital biomarker development and enriched recruitment.

Funding History

2
Total raised:$25.6M
Series A$22.8M
Seed$2.8M

Opportunities

The growing adoption of decentralized clinical trials and real-world evidence generation creates a massive opportunity for Rune Labs' platform to reduce time and cost for neurology drug development.
Furthermore, the shift towards value-based care in neurology drives demand for remote patient monitoring tools like StrivePD that can improve outcomes and reduce hospitalizations.

Risk Factors

Key risks include the challenge of driving adoption in clinical workflows, navigating evolving regulatory and reimbursement landscapes for digital tools, and competition from both established medtech companies and new digital health entrants.
Data privacy and security for sensitive neurological information is also a critical operational risk.

Competitive Landscape

Rune Labs competes in the digital neurology space with other specialized startups (e.g., Altoida, Koneksa), as well as with the data offerings from large neuromodulation device companies (Medtronic, Boston Scientific). It also faces potential competition from broader digital health platforms and the hardware/OS providers (like Apple) whose devices it relies upon.